Spinal cord tumors present unique challenges in cancer research due to their intricate location and potential to cause severe neurological deficits. These tumors can be either primary, originating within the spinal cord, or secondary, spreading from other parts of the body. Understanding their molecular characteristics and developing targeted therapies is crucial for effective treatment. Advances in imaging techniques, such as MRI and PET scans, aid in early detection and precise surgical planning. Additionally, innovative approaches like immunotherapy show promise in boosting the body's immune response against these tumors. Collaborative efforts among neurosurgeons, oncologists, and researchers are essential to unraveling the complexities of spinal cord tumors and improving patient outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States